The Prevalence and Impact of Atrial Fibrillation on Patients with Chronic Total Occlusions: Insights from the National Inpatient Sample
The impact of atrial fibrillation (AF) on patients with chronic total occlusions (CTOs) at the national level remains unclear. In this study, we conducted a retrospective analysis of data from the National Inpatient Sample to assess the characteristics and in-hospital outcomes of patients with CTO based on the presence or absence of AF. Multiple logistic and linear regressions examined factors associated with AF and evaluated its impact on length of stay (LoS), cost, and mortality. The analysis included 480,180 patients diagnosed with CTO, with AF present in 28.0% of cases. Patients with CTOs and AF were older (median age 73 vs. 66 years, <i>p</i> < 0.001) and exhibited lower female representation (25.0% vs. 27.9%, <i>p</i> < 0.001). Factors most strongly associated with AF included previous heart failure (OR 1.98, 95% CI 1.92-2.05, <i>p</i> < 0.001), liver disease (OR 1.37, 95% CI 1.27-1.48, <i>p</i> < 0.001), and obesity (OR 1.25, 95% CI 1.20-1.30, <i>p</i> < 0.001). AF correlated with increased in-hospital mortality (OR 1.29, 95% CI 1.18-1.40, <i>p</i> < 0.001), ischemic stroke (OR 1.27, 95% CI 1.13-1.42, <i>p</i> < 0.001), and major bleeding (OR 1.38, 95% CI 1.30-1.46). Moreover, AF was associated with a longer LoS (coef 1.58, 95% CI 1.50 to 1.67, <i>p</i> < 0.001) and higher in-hospital costs (coef 6.22, 95% CI 5.81 to 6.63, <i>p</i> < 0.001). Patients with CTOs and AF were older and had more underlying health problems compared to patients without AF. The patients with AF have worse outcomes in terms of mortality, ischemic stroke, major bleeding, length of stay, and costs.
Authors
- Gregor Leibundgut (ORCID: https://orcid.org/0000-0002-0122-5397)
- Julia Mascherbauer (ORCID: https://orcid.org/0000-0001-7478-1450)
- Adnan Iqbal Qureshi (ORCID: https://orcid.org/0000-0003-4962-540X)
- Gregory Y.H. Lip (ORCID: https://orcid.org/0000-0002-7566-1626)
- Konstantin Schwarz (ORCID: https://orcid.org/0000-0003-1260-4488)
- Josip A. Borovac (ORCID: https://orcid.org/0000-0002-4878-8146)
- Maximilian Will (ORCID: https://orcid.org/0000-0002-9217-0191)
- Chun Shing Kwok (ORCID: https://orcid.org/0000-0001-7047-1586)
- Eric Holroyd
- Thomas Weiß (ORCID: https://orcid.org/0000-0003-4384-6228)
Institutions
- University of Liverpool (GB)
- Mid Cheshire Hospitals NHS Foundation Trust (GB)
- University Hospitals of North Midlands NHS Trust (GB)
- University Hospital of Basel (CH)
- Liverpool Heart and Chest Hospital (GB)
- Rehabilitation Institute of Kansas City (US)
- Universitätsklinikum St. Pölten (AT)
- Karl Landsteiner University of Health Sciences (AT)
- Karl Landsteiner Society (AT)
- Liverpool John Moores University (GB)
- University of Missouri (US)
- Aalborg University (DK)
- University of Split (HR)
Publication Details
- Journal
- Journal of Cardiovascular Development and Disease
- Published
- 2025-03-14
- DOI
- https://doi.org/10.3390/jcdd12030100
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Karl Landsteiner Privatuniversität für Gesundheitswissenschaften